Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Kymera Therapeutics, Inc.

NASDAQ: KYMR · Life Sciences · 3 alerts · CIK 1815442

Share price
$125.85Close, Nov 16
Market cap
$10.7B
Shares outstanding
85.37MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Kymera Therapeutics, Inc. filings on SEC EDGAR ↗

5:20 PM ET Form 4
Insider Selling

Kymera Therapeutics CEO Nello Mainolfi Sells $3.41M of Stock

Nello Mainolfi, CEO, sold 30,000 shares of Kymera Therapeutics, Inc. at $111.44 to $116.12 a share (average $113.80) in 6 transactions, worth $3.41M in total on Oct 1, 2026. Shares held after the trade: 666,568 (-0.0%).

Value
$3.41M
Shares
30,000
Average price
$113.80
Role
CEO
Holding change
-0.0%
Trade date
Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.